Ideally… I would like to see one partnership for Nash with enough up front monies to pay for larger trials in Covid severe, Covid Critical, Covid Long Haulers mTNBC, and phase 3 HIV for Mono
I think a 100 million up front monies could kick start all those needed trials or complete those trials in progress. Then by the end of those trials… revenue from the partnership should be in hand and financing further approvals and more indications for trials to be started. That’s my dream… we only need one partner for one indication with money and we become our own pharmaceutical on all other indications… what’s ohms list up to? 90+ indications to trial? We have a lot of work to do in only 12 years after our first approval. Before our patent times out on our platform drug. We need to stay focused on the speed of it all. Good times coming is what I feel.
I think a 100 million up front monies could kick start all those needed trials or complete those trials in progress. Then by the end of those trials… revenue from the partnership should be in hand and financing further approvals and more indications for trials to be started. That’s my dream… we only need one partner for one indication with money and we become our own pharmaceutical on all other indications… what’s ohms list up to? 90+ indications to trial? We have a lot of work to do in only 12 years after our first approval. Before our patent times out on our platform drug. We need to stay focused on the speed of it all. Good times coming is what I feel.
6
